Methodology for systematic analysis of in vivo efficacy material base of traditional Chinese medicine-Chinmedomics

WANG Xi-jun1

(1.Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040)

【Abstract】The efficacy material base of traditional Chinese medicines (TCMs) is those constituents absorbed in blood and show the efficacy of TCMs after oral administration of a TCM formula. In TCM, formula consisted of more than one herbal drug is the clinical medication form which corresponding to TCM syndrome. The efficacy material base of TCMs had to be found in the condition of compatibility and efficacy of TCM formula. Therefore, we take the biological characters of TCM syndrome as a research starting point,taking formula as object,through the integration of serum pharmacochemistry of TCM methods and metabolomics technologies,establish a system research methodology of the efficacy material basis in vivo-Chinmedomics. The use of metabolomics technology is used to fully understand nature biology on syndromes or disease,identify biomarkers for disease to bridging disease animal model,establishing the biological evaluation system of traditional Chinese medicine. On the basis of the validity of the premise,the use of serum pharmacochemistry of TCM to analysis in vivo directly substance after oral prescription and dynamic law,combined with changes law of the endogenous disease biomarkers (pharmacodynamic markers of TCM),Though establishing two variable correlation analysis method between Chinese chemical compositions in serum exogenous and endogenous biomarkers,to extract TCM compositions highly correlated with the endogenous marker as potential basis for traditional Chinese medicines,and to biological validation to determine the efficacy material basis of TCM.

【Keywords】 Chinmedomics; serum pharmacochemistry of TCM; metabonomics; efficacy material base; methodology;

【DOI】

【Funds】 National Natural Science Foundation of China(Key program)(81470093)

Download this article

    References

    [1]Nickavar B,Abolhasani L.Bioactivity-guided separation of an α-amylase inhibitor flavonoid from Salvia virgata[J].Iran J Pharm Res,2013,12 (1 ):57 .

    [2]De Sousa LR,Ramalho S D,Burger M C,et al.Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems[J].J Nat Prod,2014,77 (2 ):392 .

    [3]Lou Y,Zhang H,He H,et al.Isolation and identification of phaseⅠmetabolites of curcumol in rats[J].Drug Metab Dispos,2010,38 (11 ):2014.

    [4]Xu H,Li Y,Che X,et al.Metabolism of salvianolic acid A and antioxidant activities of its methylated metabolites[J].Drug Metab Dispos,2014,42 (2 ):274 .

    [5]Kong W J,Wang J B,Zang Q C,et al.A novel"target constituent knock-out"strategy coupled with TLC,UPLC-ELSD and microcalorimetry for preliminary screening of antibacterial constituents in calculus bovis[J].J Chromatogr B Analyt Technol Biomed Life Sci,2011,879 (30 ):3565.

    [6]Wang X J.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2002,4 (2 ):1 .

    [7]Wang X J.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2010,12 (4 ):33 .

    [8]Wang H,Sun H,Zhang A,et al.Rapid identification and comparative analysis of the chemical constituents and metabolites of Phellodendri amurensis cortex and Zhibai dihuang pill by ultraperformance liquid chromatography with quadrupole TOF-MS[J].J Sep Sci,2013,36 (24 ):3874.

    [9]Wang X,Sun W,Sun H,et al.Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS[J].J Pharm Biomed Anal,2008,46 (3 ):477 .

    [10]Wang X J,Sun W J,Sun H,et al.Chinese Journal of Natural Medicines,2008,6 (1 ):43 .

    [11]Wang X J.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2013,15 (1 ):16 .

    [12]Zhang J Q,Chen Q,Liu Z H.Applied Chemical Industry,1996,4 :81 .

    [13]Tang X C.Acta Pharmacologica Sinica,1996,17 (6 ):81 .

    [14]Beijing Institute of Pharmaceutical Industry.Journal of Pharmaceuticals,1977,Z1:55 .

    [15]Li S,Chou G,Hseu Y,et al.Isolation of anticancer constituents from flos genkwa(Daphne genkwa Sieb.et Zucc.)through bioassay-guided procedures[J].Chem Cent J,2013,7 (1 ):159 .

    [16]Meng Q X,Roubin R H,Hanrahan J R.Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs[J].J Ethnopharmacol,2013,148 (1 ):229 .

    [17]Huang X,Chen K J.Journal of Traditional Chinese Medicine,1997,38 (12 ):745 .

    [18]Huang X.Journal of the Fourth Military Medical University,1999,20 (4 ):277 .

    [19]Huang X,Fan R,Zhang H N,et al.Chinese Traditional and Herbal Drugs,2010,41 (3 ):337 .

    [20]Qiu F,Yao X S.Pharmacology and Clinics of Chinese Materia Medica,1999,15 (3 ):1 .

    [21]Qiu F.International Journal of Pharmaceutical Research,2010,37 (5 ):321 .

    [22]Yang X W.China Journal of Chinese Materia Medica,2007,32 (5 ):365 .

    [23]Yang X W, Zhang P,Kou G F,et al.Beijing: The 9th integrated traditional Chinese and Western medicine seminar.2009:302 .

    [24]Xu H Y,Tang S H,Chen J X,et al.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2011,13 (1 ):30 .

    [25]Qi L W,Zhou J L,Hao H P,et al.Journal of China Pharmaceutical University,2010,41 (3 ):195 .

    [26]Gong P,Cui N,Wu L,et al.Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures[J].Anal Chem,2012,84 (6 ):2995.

    [27]Yang M,Cheng C,Yang J,et al.Metabolite profiling and characterization for medicinal herbal remedies[J].Curr Drug Metab,2012,13 (5 ):535 .

    [28]Liu Z,Liu M,Qi Y,et al.Plasma pharmacochemistry combined with microdialysis to screen potential bioactive components and their metabolites in Anemarrhena asphodeloides saponin extract using ultrahigh-performance liquid chromatography/quadrupoletime-of-flight mass spectrometry[J].J Sep Sci,2013,36 (9 /10 ):1659.

    [29]Hu Y,Jiang P,Wang S,et al.Plasma pharmacochemistry based approach to screening potential bioactive components in HuangLian-Jie-Du-Tang using high performance liquid chromatography coupled with mass spectrometric detection[J].J Ethnopharmacol,2012,141 (2 ):728 .

    [30]Zeng W,Han H,Tao Y,et al.Identification of bio-active metabolites of gentiopicroside by UPLC/Q-TOF MS and NMR[J].Biomed Chromatogr,2013,27 (9 ):1129.

    [31]Pan X Q,Wu Y C,Gong M X,et al.China Journal of Chinese Materia Medica,2014,39 (1 ):126 .

    [32]Wang X,Sun W,Sun H,et al.Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS[J].J Pharm Biomed Anal,2008,46 (3 ):477 .

    [33]Wang X,Sun H,Zhang A,et al.Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight mass spectrometry combined with pattern recognition methods[J].Analyst,2011,136 (23 ):5068.

    [34]Lv H,Sun H,Sun W,et al.Pharmacokinetic studies of a Chinese triple herbal drug formula[J].Phytomedicine,2008,15 (11 ):993 .

    [35]Wang X J,Sun W J,Zhang N,et al.Chinese Journal of Natural Medicines,2007,5 (4 ):277 .

    [36]Wang X J,Zhang N,Sun H,et al.Chinese Journal of Natural Medicines,2004,2 (4 ):219 .

    [37]Wu F F,Wang X J,Han Y,et al.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2010,12 (4 ):657 .

    [38]Wang X J,Chen X,Yang G,et al.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2007,9 (2 ):54 .

    [39]Cao H,Chen X,Sun H,et al.Pharmacokinetics-based elucidation on disparity in clinical effectiveness between varieties of Zhi Zhu Wan,a traditional Chinese medical formula[J].J Ethnopharmacol,2010,128 (3 ):606 .

    [40]Yang B,Zhang A H,Dong W,et al.Information on Traditional Chinese Medicine,2013,30 (4 ):44 .

    [41]Yan G L,Zhang A H,Sun H,et al.An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach[J].J Sep Sci,2013,36 (19 ):3191.

    [42]Wang Ping,Yin Quanwei,Zhang Aihua,et al.Preliminary iden-tification of the absorbed bioactive components and metabolites in rat plasma after oral administration of Shaoyao-Gancao decoction by ultra-performance liquid chromatography with electrospray ionization tandem mass spectrometry[J].Pharmacogn Mag,2014,10 (40 ):497 .

    [43]Cao H X,Wang X J,Yu Y H,et al.China Journal of Chinese Materia Medica,2004,29 (3 ):281 .

    [44]Wang X J.Traditional Chinese Medcine serum pharmacochemistry.Beijing:Chinese Science Publishing & Media, Ltd.,2010.

    [45]Wang X J.Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology,2013,15 (1 ):16 .

    [46]Wang X,Zhang A,Sun H.Future perspectives of Chinese medical formulae:chinmedomics as an effector[J].OMICS,2012,16 (7 /8):414 .

    [47]Wang X,Zhang A,Han Y,et al.Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease[J].Mol Cell Proteomics,2012,11 (8 ):370 .

    [48]Wang X,Zhang A,Sun H.Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma[J].Hepatology,2013,57 (5 ):2072.

    [49]Wang X,Yang B,Sun H,et al.Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets[J].Anal Chem,2012,84 (1 ):428 .

    [50]Wang X,Wang H,Zhang A,et al.Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis[J].J Proteome Res,2012,11 (2 ):1284.

    [51]Wang X,Yang B,Zhang A,et al.Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach[J].J Proteomics,2012,75 (4 ):1411.

    [52]Zhang A,Sun H,Han Y,et al.Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system[J].PLo S One,2013,8 (5 ):e64381.

    [53]Zhang A,Sun H,Han Y,et al.Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach[J].Analyst,2012,137 (18 ):4200.

    [54]Zhang A H,Sun H,Yan G L,et al.China Journal of Chinese Materia Medica,2013,38 (21 ):3786.

This Article

ISSN:1001-5302

CN: 11-2272/R

Vol 40, No. 01, Pages 13-17

January 2015

Downloads:4

Share
Article Outline

Abstract

References